Tower Research Capital (TRC)’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53K | Sell |
2,538
-2,153
| -46% | -$4.69K | ﹤0.01% | 4178 |
|
|
2025
Q1 | $5.63K | Buy |
4,691
+2,069
| +79% | +$2.48K | ﹤0.01% | 4104 |
|
|
2024
Q4 | $4.46K | Buy |
2,622
+1,149
| +78% | +$1.95K | ﹤0.01% | 4459 |
|
|
2024
Q3 | $3.46K | Sell |
1,473
-489
| -25% | -$1.15K | ﹤0.01% | 4842 |
|
|
2024
Q2 | $5.73K | Sell |
1,962
-1,064
| -35% | -$3.11K | ﹤0.01% | 4658 |
|
|
2024
Q1 | $9.2K | Buy |
3,026
+743
| +33% | +$2.26K | ﹤0.01% | 3882 |
|
|
2023
Q4 | $6.48K | Sell |
2,283
-3,471
| -60% | -$9.86K | ﹤0.01% | 4735 |
|
|
2023
Q3 | $15.5K | Sell |
5,754
-1,418
| -20% | -$3.83K | ﹤0.01% | 3607 |
|
|
2023
Q2 | $11.5K | Buy |
7,172
+5,446
| +316% | +$8.71K | ﹤0.01% | 3946 |
|
|
2023
Q1 | $4K | Buy |
1,726
+113
| +7% | +$262 | ﹤0.01% | 5044 |
|
|
2022
Q4 | $6K | Sell |
1,613
-892
| -36% | -$3.32K | ﹤0.01% | 4680 |
|
|
2022
Q3 | $10K | Buy |
2,505
+424
| +20% | +$1.69K | ﹤0.01% | 4510 |
|
|
2022
Q2 | $29K | Buy |
2,081
+710
| +52% | +$9.89K | ﹤0.01% | 3398 |
|
|
2022
Q1 | $30K | Sell |
1,371
-85
| -6% | -$1.86K | ﹤0.01% | 3136 |
|
|
2021
Q4 | $39K | Buy |
1,456
+1,379
| +1,791% | +$36.9K | ﹤0.01% | 2964 |
|
|
2021
Q3 | $4K | Sell |
77
-462
| -86% | -$24K | ﹤0.01% | 4950 |
|
|
2021
Q2 | $54K | Buy |
539
+468
| +659% | +$46.9K | ﹤0.01% | 2963 |
|
|
2021
Q1 | $11K | Sell |
71
-57
| -45% | -$8.83K | ﹤0.01% | 4300 |
|
|
2020
Q4 | $15K | Buy |
128
+19
| +17% | +$2.23K | ﹤0.01% | 4039 |
|
|
2020
Q3 | $26K | Buy |
109
+92
| +541% | +$21.9K | ﹤0.01% | 3771 |
|
|
2020
Q2 | $5K | Buy |
+17
| New | +$5K | ﹤0.01% | 4261 |
|
|
2019
Q3 | – | Sell |
-4
| Closed | -$2K | – | 4078 |
|
|
2019
Q2 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 3234 |
|